Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-07 4:52 pm Purchase | 2025-09-30 | 13G | Processa Pharmaceuticals, Inc. PCSA | CVI Investments, Inc. | 200,000 9.000% | 21,157 (+11.83%) | Filing History |
| 2025-10-15 12:28 pm Unchanged | 2025-08-05 | 13D | Processa Pharmaceuticals, Inc. PCSA | Chiliz Group Ltd. | 218,687 10.900% | 0 (Unchanged) | Filing History |
| 2025-08-14 9:29 pm Purchase | 2025-06-30 | 13G | Processa Pharmaceuticals, Inc. PCSA | Armistice Capital, LLC | 105,775 4.990% | 82,631 (+357.03%) | Filing History |
| 2025-08-14 2:01 pm Purchase | 2025-06-30 | 13G | Processa Pharmaceuticals, Inc. PCSA | CVI Investments, Inc. | 178,843 9.900% | 72,320 (+67.89%) | Filing History |
| 2025-08-13 2:50 pm Purchase | 2025-08-05 | 13D | Processa Pharmaceuticals, Inc. PCSA | Chiliz Group Ltd. | 218,687 10.900% | 218,687 (New Position) | Filing History |
| 2025-08-12 5:12 pm Sale | 2025-06-30 | 13G | Processa Pharmaceuticals, Inc. PCSA | Mitchell P. Kopin | 116,290 9.990% | -4,440 (-3.68%) | Filing History |
| 2025-06-24 10:00 am Purchase | 2025-06-17 | 13G | Processa Pharmaceuticals, Inc. PCSA | CVI Investments, Inc. | 106,523 9.900% | 106,523 (New Position) | Filing History |
| 2025-06-23 5:54 pm Purchase | 2025-06-17 | 13G | Processa Pharmaceuticals, Inc. PCSA | 3i, LP | 67,278 4.900% | 67,278 (New Position) | Filing History |
| 2025-06-23 06:03 am Purchase | 2025-06-17 | 13G | Processa Pharmaceuticals, Inc. PCSA | Mitchell P. Kopin | 120,730 9.990% | 120,730 (New Position) | Filing History |
| 2025-05-15 3:27 pm Purchase | 2025-03-31 | 13G | Processa Pharmaceuticals, Inc. PCSA | Armistice Capital, LLC | 23,144 9.990% | 23,144 (New Position) | Filing History |
| 2021-08-10 5:02 pm Purchase | 2021-08-04 | 13G | Processa Pharmaceuticals, Inc. PCSA | MANCHESTER MANAGEMENT COMPANY, LLC | 285 0.900% | 285 (New Position) | Filing History |
| 2021-06-11 1:11 pm Purchase | 2020-10-02 | 13G | Processa Pharmaceuticals, Inc. PCSA | YUHAN (USA) CORP | 1,500 7.300% | 1,500 (New Position) | Filing History |
| 2021-04-08 5:15 pm Sale | 2021-04-07 | 13G | Processa Pharmaceuticals, Inc. PCSA | MANCHESTER MANAGEMENT COMPANY, LLC | 2,107 6.800% | -953 (-31.16%) | Filing History |